FDA Moves Ahead With MMJ Cannabis Drug Application

MMJ International Holdings Develops Botanical Extract for FDA Clinical Trials in Multiple Sclerosis and Huntington's Disease. MMJ International Holdings has manufactured a botanical extract in a final dose form gel cap and will investigate its novel cannabis medicine in FDA clinical trials to prove